Announcements Trials
Browse Landscape

Phase

Phase 2 120Phase 1 50Phase 3 46Phase 1/2 31Phase NA 14Phase EARLY_PHASE1 3Phase 4 2

Status

Completed 22Recruiting 9Unknown 8Not yet recruiting 6Withdrawn 3Terminated 2Active not recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Plasma cell 2

Conditions

Breast Neoplasms 8Prostatic Neoplasms 6Papillomavirus Infections 6Neoplasms 6Polycystic Ovary Syndrome 3Colorectal Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Tuberous Sclerosis 2Thyroid Neoplasms 2Stomach Neoplasms 2Smoking Cessation 2Sarcoma 2Rectal Neoplasms 2Pancreatic Neoplasms 2Multiple Myeloma 2Leukemia, Myeloid, Acute 2Hematologic Neoplasms 2Head and Neck Neoplasms 2Graft vs Host Disease 2Dupuytren Contracture 2Diabetes Mellitus 2Dementia 2Cardiovascular Diseases 2Carcinoma, Hepatocellular 2Wrist Fractures 1Vaccine-Preventable Diseases 1Uterine Cervical Neoplasms 1Tobacco Use Cessation 1Thyroid Diseases 1Thalassemia 1

Interventions

daratumumab 1Prednisone 1Melphalan 1Lenalidomide 1Dexamethasone 1Bortezomib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × Active not recruiting × Multiple Myeloma × Clear all
NCT03829371 2025-12-03

STUDY COMPARING TWO STANDARD TREATMENTS IN AUTOLOGOUS STEM CELL TRANSPLANTATION INELIGIBLE POPULATION AFFECTED BY MULTIPLE MYELOMA

University of Turin, Italy

Phase 4 Active not recruiting
450 enrolled
Plasma cell

Multiple Myeloma

NCT07154537 2025-09-04

Pneumococcal Conjugated Vaccine 13 (PCV13) for Patients With Multiple Myeloma (MM)

National Taiwan University Hospital

Phase 4 Active not recruiting
101 enrolled
Plasma cell

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡